Colchicine Tablet
Product Images NDC 50268-187

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colchicine (NDC 50268-187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

.6 (187 15 0.6mg)

.6 (187 15 0.6mg)
This is a description of a prescription drug identified by its National Drug Code (NOC) of 50268.187.15. The drug is in the form of tablets and is a USP formulation with a dosage of 06mg. The package contains 50 tablets in unit dose packs and can only be obtained through a doctor's prescription. The drug's manufacturer is not specifically identified but has a name resembling "Pl donsswit Medston Gids." Some information about the drug's application is given, discussing the relief of paralysis or pain, but full details need to be obtained through a doctor's prescription or the package instructions. The drug's production date seems to be January 20, 2001.*
FDA Label Image

30a820b8-figure-01 (Colchicine Tablets Usp 1)

30a820b8-figure-01 (Colchicine Tablets Usp 1)
FDA Label Image

1 (Colchicine Tablets Usp 2)

1 (Colchicine Tablets Usp 2)
The text is a graph showing the percentage of patient improvement with different dosages of Colchicine compared to a placebo. The X-axis shows the increasing numerical range from 0 to 2100, whereas the Y-axis measures improvement percentages ranging from 0 to 90. There are three lines: one represents a low dose of colchicine, the second represents a high dose, and the third line represents the placebo group. The improvement percentage for the high dose line is the highest, followed by the low dose and placebo groups.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.